Alex Yuan

Alex Yuan

Auto-generated profile, based on publicly available information

Alex Yuan

Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AYAlex Yuan
Alex Yuan
EFErica L. Farber
Erica L. Farber
ARAna Lia Rapoport
Ana Lia Rapoport
DTDesiree Tejada
Desiree Tejada
RDRoman Deniskin
Roman Deniskin
DFDebora B. Farber
Debora B. Farber
Microvesicles are plasma membrane-derived vesicles released into the extracellular environment by a variety of cell types. Originally characterized from platelets, microvesicles are a normal constituent of human plasma, where they play an important role in maintaining hematostasis. Microvesicles have been shown to transfer proteins and RNA from cell to cell and they are also believed to play a role in intercellular communication. We characterized the RNA and protein content of embryonic stem cell microvesicles and show that they can be engineered to carry exogenously expressed mRNA and protein such as green fluorescent protein (GFP). We demonstrate that these engineered microvesicles dock and fuse with other embryonic stem cells, transferring their GFP. Additionally, we show that embryonic stem cells microvesicles contain abundant microRNA and that they can transfer a subset of microRNAs to mouse embryonic fibroblasts in vitro. Since microRNAs are short (21–24 nt), naturally occurring RNAs that regulate protein translation, our findings open up the intriguing possibility that stem cells can alter the expression of genes in neighboring cells by transferring microRNAs contained in microvesicles. Embryonic stem cell microvesicles may be useful therapeutic tools for transferring mRNA, microRNAs, protein, and siRNA to cells and may be important mediators of signaling within stem cell niches.

1 March 2003 in Neuron
Verified
Journal Article
Closed access
AYAlex Yuan
Alex Yuan
CSCelia M. Santi
Celia M. Santi
AWAguan Wei
Aguan Wei
ZWZhao-Wen Wang
Zhao-Wen Wang
KPKelly Pollak
Kelly Pollak
LSLawrence Salkoff
Lawrence Salkoff

1 February 1998 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MSMatthew Schreiber
Matthew Schreiber
AWAguan Wei
Aguan Wei
AYAlex Yuan
Alex Yuan
JGJoseph Gaut
Joseph Gaut
MSMitsuyoshi Saito
Mitsuyoshi Saito
LSLawrence Salkoff
Lawrence Salkoff
Potassium channels have evolved to play specialized roles in both excitable and inexcitable tissues. Here we describe the cloning and expression of Slo3, a novel potassium channel abundantly expressed in mammalian spermatocytes. Slo3 represents a new and unique type of potassium channel regulated by both intracellular pH and membrane voltage. Reverse transcription-polymerase chain reaction, Northern analysis, and in situ hybridization show that Slo3 is primarily expressed in testis in both mouse and human. Because of its sensitivity to both pH and voltage, Slo3 could be involved in sperm capacitation and/or the acrosome reaction, essential steps in fertilization where changes in both intracellular pH and membrane potential are known to occur. The protein sequence of mSlo3 (the mouse Slo3 homologue) is similar to Slo1, the large conductance, calcium- and voltage-gated potassium channel. These results suggest that Slo channels comprise a multigene family, defined by a combination of sensitivity to voltage and a variety of intracellular factors. Northern analysis from human testis indicates that a Slo3 homologue is present in humans and conserved with regard to sequence, transcript size, and tissue distribution. Because of its high testis-specific expression, pharmacological agents that target human Slo3 channels may be useful in both the study of fertilization as well as in the control or enhancement of fertility.

1 May 1999 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
MSMatthew Schreiber
Matthew Schreiber
AYAlex Yuan
Alex Yuan
LSLawrence Salkoff
Lawrence Salkoff

1 July 2018 in Ophthalmology
Verified
Journal Article
Closed access
Justis P. EhlersJustis P. Ehlers
Justis P. Ehlers
YMYasha S. Modi
Yasha S. Modi
PPPaula E. Pecen
Paula E. Pecen
JGJeff Goshe
Jeff Goshe
WDWilliam J. Dupps
William J. Dupps
SSSunil K. Srivastava
Sunil K. Srivastava

23 October 2012 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
DDDilsher S Dhoot
Dilsher S Dhoot
SHSiya Huo
Siya Huo
AYAlex Yuan
Alex Yuan
DXDavid Xu
David Xu
SSSunil Srivistava
Sunil Srivistava
PKPeter K Kaiser
Peter K Kaiser
Objective To describe the choroidal characteristics of patients with retinitis pigmentosa (RP) using enhanced depth imaging (EDI) and spectral domain (SD) optical coherence tomography (OCT). Purpose To investigate the spectral-domain ocular coherence tomography features of the choroid in patients with RP using EDI. Methods A prospective, case–control study of 21 patients from the Cole Eye Institute with RP imaged using the Spectralis OCT and an EDI protocol. Submacular choroidal thickness measurements were obtained beneath the fovea and at 500 µm intervals for 2.5 mm nasal and temporal to the centre of the fovea. These measurements were compared to choroidal thickness measurements from 25 healthy age-matched controls with similar refractive error range and no clinical evidence of retinal or glaucomatous disease. Statistical analysis was performed to compare choroidal thickness at each location between the two groups and to correlate choroidal thickness with best-corrected visual acuity and central retinal thickness. Results Mean ages were 40.6 years for control patients and 45.1 years for RP patients (p>0.05). Mean choroidal thickness measurements were 245.6±103 µm in RP patients and 337.8.2±109 µm in controls (p<0.0001). There was no correlation between subfoveal choroidal thickness and visual acuity or retinal thickness in the RP patients when compared to the control group. Conclusions Submacular choroidal thickness, as measured by SD–OCT EDI, is significantly reduced in patients with RP, but did not correlate with visual acuity or retinal thickness in RP patients. Further research is needed to understand better the pathophysiological significance of the choroidal alterations present in RP.